In the year 2000 the U.S.

Food and Drug Administration (FDA) approved the drug mifepristone (also known

as RU-486 or Mifeprex) as part of a regimen for chemically induced abortions.

But on April 7, 2023—late on Good Friday—a federal judge in Texas issued a

preliminary injunction that suspended the FDA’s approval of mifepristone,

pending a trial on the merits of the case. The preliminary injunction was

partially reversed on appeal, but the judge’s opinion in Alliance for

Hippocratic Medicine v. FDA casts a spotlight on the damage that

mifepristone has caused to women and their preborn children. Host Michael

Pauley is joined by Adam Schwend of Susan B. Anthony Pro-Life America to

discuss the implications of the Alliance for Hippocratic Medicine case,

regarded by many legal experts as the most important abortion-related

litigation since the Dobbs decision.